Adma Biologics ADMA
NASDAQ ADMA
$9.72 -0.21 (-2.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Return on Capital Employed [ROCE] (2012 - 2026)

Updated

Adma Biologics' Return on Capital Employed [ROCE] was 37.48% in Q2 2026, up 3.61 percentage points from 33.87% a year earlier but down 0.13 percentage points from the prior quarter.

Analysis

Adma Biologics (ADMA) Return on Capital Employed [ROCE] (2012 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Adma Biologics came in at 39.32%, down 0.01 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of +83.35 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was 39.33% in FY2024 (+31.84 pp), 7.48% in FY2023 (+21.90 pp), -14.41% in FY2022 (+13.17 pp) and -27.59% in FY2021 (+16.44 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -30.68% (Q3 2021) and 37.61% (Q1 2026) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has increased for three straight quarters, with an average year-over-year change of +11.84 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2024 (a gain of 33.49 percentage points); the worst was Q3 2025 (a drop of 0.99 percentage points).
  • Per Business Quant data, ADMA's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was 37.61% (Q1 2026), 36.33% (Q4 2025) and 32.94% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Adma Biologics 2.24 Bn 1.81 Bn 86.28 Mn 37.48%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.48%
Mar 31, 2026 37.61%
Dec 31, 2025 36.33%
Sep 30, 2025 32.94%
Jun 30, 2025 33.87%
Mar 31, 2025 34.08%
Dec 31, 2024 36.18%
Sep 30, 2024 33.93%
Jun 30, 2024 26.28%
Mar 31, 2024 15.43%
Dec 31, 2023 7.48%
Sep 30, 2023 0.44%
Jun 30, 2023 -5.55%
Mar 31, 2023 -8.24%
Dec 31, 2022 -13.80%
Sep 30, 2022 -18.28%
Jun 30, 2022 -18.81%
Mar 31, 2022 -22.27%
Dec 31, 2021 -25.71%
Sep 30, 2021 -30.68%
API Access

Adma Biologics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ADMA&period=max&api_key=YOUR_API_KEY